Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
970 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | Healthcare | $371.20M | $2.13 | −25.52% | +5.45% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | $368.27M | $3.89 | −44.03% | −15.80% |
| LYEL | Lyell Immunopharma, Inc. | Healthcare | $362.68M | $15.49 | −65.58% | +19.25% |
| DMAC | DiaMedica Therapeutics Inc. | Healthcare | $361.30M | $6.70 | −35.70% | +0.90% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| CATX | Perspective Therapeutics, Inc. | Healthcare | $360.72M | $3.16 | −48.70% | +10.10% |
| STRO | Sutro Biopharma, Inc. | Healthcare | $355.50M | $21.43 | −51.13% | −9.69% |
| VMD | Viemed Healthcare, Inc. | Healthcare | $355.36M | $9.33 | −26.01% | −21.73% |
| SABS | SAB Biotherapeutics, Inc. | Healthcare | $353.03M | $3.88 | −24.66% | +12.46% |
| IKT | Inhibikase Therapeutics, Inc. | Healthcare | $347.44M | $2.49 | −1.97% | +7.79% |
| ABEO | Abeona Therapeutics Inc. | Healthcare | $343.68M | $6.01 | −21.44% | −0.17% |
| IMRX | Immuneering Corporation | Healthcare | $333.19M | $5.15 | −48.91% | +21.46% |
| P2OD34.SA | Insulet Corporation | Healthcare | $332.45M | 24.68 BRL | −26.24% | −12.58% |
| RCEL | AVITA Medical, Inc. | Healthcare | $327.52M | $10.59 | −1.67% | +129.72% |
| AVH.AX | AVITA Medical, Inc. | Healthcare | $324.65M | 2.87 AUD | −2.88% | +117.05% |
| VNDA | Vanda Pharmaceuticals Inc. | Healthcare | $323.48M | $5.35 | −46.18% | +3.68% |
| SMTI | Sanara MedTech Inc. | Healthcare | $318.55M | $34.65 | −3.62% | +30.07% |
| OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | $316.15M | $5.26 | −9.00% | +36.27% |
| IRD | Opus Genetics, Inc. | Healthcare | $316.14M | $3.80 | −34.60% | +11.44% |
| RNAC | Cartesian Therapeutics, Inc. | Healthcare | $308.30M | $10.19 | −13.64% | +33.20% |
| TMCI | Treace Medical Concepts, Inc. | Healthcare | $306.96M | $4.72 | −39.33% | +17.71% |
| EBS | Emergent BioSolutions Inc. | Healthcare | $306.10M | $5.97 | −57.54% | −18.33% |
| FATE | Fate Therapeutics, Inc. Common Stock | Healthcare | $305.54M | $2.57 | −20.43% | +10.78% |
| TLSI | TriSalus Life Sciences, Inc. | Healthcare | $303.56M | $4.93 | −37.99% | +13.86% |
| AVXL | Anavex Life Sciences Corp. | Healthcare | $300.34M | $3.24 | −68.85% | +26.07% |
| MYGN | Myriad Genetics, Inc. | Healthcare | $298.43M | $3.12 | −63.68% | −41.35% |
| TRDA | Entrada Therapeutics, Inc. | Healthcare | $296.70M | $7.00 | −57.45% | +20.07% |
| BDSX | Biodesix, Inc. | Healthcare | $296.22M | $30.60 | −2.27% | +45.51% |
| FULC | Fulcrum Therapeutics, Inc. | Healthcare | $294.51M | $3.86 | −75.48% | +3.76% |
| NMRA | Neumora Therapeutics, Inc. | Healthcare | $293.12M | $1.56 | −57.26% | −7.14% |
| TTRX | Turn Therapeutics Inc. | Healthcare | $292.44M | $9.63 | −63.66% | +25.06% |
| CV | CapsoVision, Inc. | Healthcare | $291.27M | $5.82 | −62.13% | −12.08% |
| ANIK | Anika Therapeutics, Inc. | Healthcare | $290.14M | $21.68 | −5.24% | +43.10% |
| EMBC | Embecta Corp. | Healthcare | $285.00M | $4.96 | −68.10% | +38.16% |
| LCTX | Lineage Cell Therapeutics, Inc. | Healthcare | $283.26M | $1.12 | −46.41% | +4.67% |
| SION | Sionna Therapeutics, Inc. | Healthcare | $282.58M | $6.17 | −88.78% | −86.75% |
| PYXS | Pyxis Oncology, Inc. | Healthcare | $278.58M | $3.34 | −39.82% | +14.78% |
| WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $275.92M | $4.84 | −11.92% | +31.52% |
| SRZN | Surrozen, Inc. | Healthcare | $274.56M | $23.71 | −32.26% | +22.22% |
| ALXO | ALX Oncology Holdings Inc. | Healthcare | $273.79M | $1.98 | −25.56% | −0.50% |
| ELDN | Eledon Pharmaceuticals, Inc. | Healthcare | $272.22M | $3.35 | −27.17% | −1.47% |
| GLSI | Greenwich LifeSciences, Inc. | Healthcare | $267.58M | $18.23 | −46.54% | +35.54% |
| ELMD | Electromed, Inc. | Healthcare | $265.79M | $31.77 | −32.97% | −19.53% |
| IVVD | Invivyd, Inc. | Healthcare | $265.78M | $0.90 | −70.63% | +52.06% |
| RXST | RxSight, Inc. | Healthcare | $265.36M | $6.38 | −51.74% | +5.45% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Healthcare | $263.56M | $4.20 | −45.81% | +22.81% |
| ALEC | Alector, Inc. | Healthcare | $263.51M | $2.46 | −27.65% | +61.84% |
| NAGE | Niagen Bioscience, Inc. | Healthcare | $260.44M | $3.30 | −68.63% | +0.30% |
| NERV | Minerva Neurosciences, Inc. | Healthcare | $259.27M | $5.43 | −56.42% | +26.87% |
| MGNX | MacroGenics, Inc. Common Stock | Healthcare | $257.35M | $4.04 | −20.47% | +4.94% |
| OSUR | OraSure Technologies, Inc. | Healthcare | $255.87M | $3.71 | −19.00% | −7.71% |
| R2AR34.SA | Ultragenyx Pharmaceutical Inc. | Healthcare | $255.25M | 13.33 BRL | −28.49% | −16.48% |
| LAB | Standard BioTools Inc. | Healthcare | $255.18M | $0.65 | −62.10% | −17.49% |
| AKBA | Akebia Therapeutics, Inc. | Healthcare | $251.20M | $0.91 | −72.70% | −28.62% |
| PEPG | PepGen Inc. | Healthcare | $237.21M | $3.22 | −58.72% | +75.96% |
| RNA | Prosensa Holding B.V. Ordinary Shares | Healthcare | $236.91M | $13.85 | −17.41% | +20.54% |
| DTIL | Precision BioSciences, Inc. | Healthcare | $234.34M | $8.49 | −11.75% | +18.41% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | Healthcare | $233.94M | $13.64 | −65.42% | +37.22% |
| TARA | Protara Therapeutics, Inc. | Healthcare | $231.06M | $3.91 | −50.00% | −0.76% |
| STIM | Neuronetics, Inc. | Healthcare | $227.07M | $3.00 | −19.14% | +60.43% |
| UTMD | Utah Medical Products, Inc. | Healthcare | $225.70M | $70.89 | −6.42% | −0.10% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.